Previous close | 94.74 |
Open | 94.49 |
Bid | 96.67 x 0 |
Ask | 96.97 x 0 |
Day's range | 94.49 - 95.20 |
52-week range | 85.26 - 110.94 |
Volume | |
Avg. volume | 2 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 18 Jul 2024 - 22 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Abbott's (ABT) share recovery in the Nutrition business buoys optimism.
UnitedHealth, Danaher, Abbott and Ark Restaurants are included in this Analyst Blog.